Answers are grounded in this paper and cite their sources.
Cohort study observes patterns of lipid-lowering therapy intensity in patients with polyvascular disease, highlighting potential gaps in cardiovascular risk management.
This cohort study assesses patterns in treatment of low-density lipoprotein cholesterol using lipid-lowering therapy among patients with and without polyvascular disease.
No takes yet. Share an insight, caveat, or question.
Peterson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: